In vivo imaging of transplanted stem cells in the central nervous system

Current Opinion in Genetics and Development

Volumn 28, Issue , 2014, Pages 83-88

  Duffy, Ben A ^a   Weitz, Andrew J ^b   Lee, Jin Hyung ^a,b,c  

^a STANFORD UNIVERSITY   (United States)

^b Stanford University   (United States)

^c Department of Neurosurgery Stanford University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2BETA CARBOMETHOXY 3BETA (4 FLUOROPHENYL)TROPANE C 11; 6 FLUORODOPA F 18; BIOLOGICAL MARKER; FERRITIN; FLUOROCARBON; GADOLINIUM; IRON OXIDE; LUCIFERASE; POLYMER; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

BIOLUMINESCENCE; BOLD SIGNAL; BRAIN ATROPHY; CELL LABELING; CENTRAL NERVOUS SYSTEM; DIFFUSION TENSOR IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PHASE 2 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPORTER GENE; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; ANIMAL; BRAIN; CYTOLOGY; MOLECULAR IMAGING; PHYSIOLOGY;

ANIMALS; BRAIN; HUMANS; MOLECULAR IMAGING; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84909594802     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2014.09.007     Document Type: Review

References (54)

1. Trounson A., Thakar R.G., Lomax G., Gibbons D. Clinical trials for stem cell therapies. BMC Med 2011, 9:52.
2. Martinez-Morales P.L., Revilla A., Ocana I., Gonzalez C., Sainz P., McGuire D., Liste I. Progress in stem cell therapy for major human neurological disorders. Stem Cell Rev 2013, 9:685-699.
3. Lees J.S., Sena E.S., Egan K.J., Antonic A., Koblar S.A., Howells D.W., Macleod M.R. Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J Stroke 2012, 7:582-588.
4. Antonic A., Sena E.S., Lees J.S., Wills T.E., Skeers P., Batchelor P.E., Macleod M.R., Howells D.W. Stem cell transplantation in traumatic spinal cord injury: a systematic review and meta-analysis of animal studies. PLoS Biol 2013, 11:e1001738.
5. Andres R.H., Horie N., Slikker W., Keren-Gill H., Zhan K., Sun G., Manley N.C., Pereira M.P., Sheikh L.A., McMillan E.L., et al. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 2011, 134:1777-1789.
6. Kim J.H., Auerbach J.M., Rodriguez-Gomez J.A., Velasco I., Gavin D., Lumelsky N., Lee S.H., Nguyen J., Sanchez-Pernaute R., Bankiewicz K., et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002, 418:50-56.
7. Wernig M., Zhao J.P., Pruszak J., Hedlund E., Fu D., Soldner F., Broccoli V., Constantine-Paton M., Isacson O., Jaenisch R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A 2008, 105:5856-5861.
8. Daadi M.M., Li Z., Arac A., Grueter B.A., Sofilos M., Malenka R.C., Wu J.C., Steinberg G.K. Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther 2009, 17:1282-1291.
9. Oki K., Tatarishvili J., Wood J., Koch P., Wattananit S., Mine Y., Monni E., Tornero D., Ahlenius H., Ladewig J., et al. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 2012, 30:1120-1133.
10. Amariglio N., Hirshberg A., Scheithauer B.W., Cohen Y., Loewenthal R., Trakhtenbrot L., Paz N., Koren-Michowitz M., Waldman D., Leider-Trejo L., et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009, 6:e1000029.
11. Seminatore C., Polentes J., Ellman D., Kozubenko N., Itier V., Tine S., Tritschler L., Brenot M., Guidou E., Blondeau J., et al. The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke 2010, 41:153-159.
12. 18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity. J Nucl Med 2013, 54:447-454.
13. Hoehn M., Kustermann E., Blunk J., Wiedermann D., Trapp T., Wecker S., Focking M., Arnold H., Hescheler J., Fleischmann B.K., et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 2002, 99:16267-16272.
14. Modo M., Beech J.S., Meade T.J., Williams S.C., Price J. A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage 2009, 47(Suppl. 2):T133-T142.
15. Karussis D., Karageorgiou C., Vaknin-Dembinsky A., Gowda-Kurkalli B., Gomori J.M., Kassis I., Bulte J.W., Petrou P., Ben-Hur T., Abramsky O., et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010, 67:1187-1194.
16. Zhu J., Zhou L., Xing Wu F. Tracking neural stem cells in patients with brain trauma. Int N Engl J Med 2006, 355:2376-2378.
17. Kraitchman D.L., Tatsumi M., Gilson W.D., Ishimori T., Kedziorek D., Walczak P., Segars W.P., Chen H.H., Fritzges D., Izbudak I., et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005, 112:1451-1461.
18. Seo W.S., Lee J.H., Sun X., Suzuki Y., Mann D., Liu Z., Terashima M., Yang P.C., McConnell M.V., Nishimura D.G., et al. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents. Nat Mater 2006, 5:971-976.
19. Li Z., Suzuki Y., Huang M., Cao F., Xie X., Connolly A.J., Yang P.C., Wu J.C. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 2008, 26:864-873.
20. Thu M.S., Bryant L.H., Coppola T., Jordan E.K., Budde M.D., Lewis B.K., Chaudhry A., Ren J., Varma N.R., Arbab A.S., et al. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med 2012, 18:463-467.
21. Liang Y., Walczak P., Bulte J.W. Comparison of red-shifted firefly luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter genes for in vivo imaging of stem cells. J Biomed Opt 2012, 17:016004.
22. Bernau K., Lewis C.M., Petelinsek A.M., Benink H.A., Zimprich C.A., Meyerand M.E., Suzuki M., Svendsen C.N. In vivo tracking of human neural progenitor cells in the rat brain using bioluminescence imaging. J Neurosci Methods 2014, 228:67-78.
23. Iordanova B., Ahrens E.T. In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration. Neuroimage 2012, 59:1004-1012.
24. Vande Velde G., Rangarajan J.R., Toelen J., Dresselaers T., Ibrahimi A., Krylychkina O., Vreys R., Van der Linden A., Maes F., Debyser Z., et al. Evaluation of the specificity and sensitivity of ferritin as an MRI reporter gene in the mouse brain using lentiviral and adeno-associated viral vectors. Gene Ther 2011, 18:594-605.
25. Min J.J., Gambhir S.S. Gene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects. Gene Ther 2004, 11:115-125.
26. Daadi M.M., Hu S., Klausner J., Li Z., Sofilos M., Sun G., Wu J.C., Steinberg G.K. Imaging neural stem cell graft-induced structural repair in stroke. Cell Transplant 2013, 22:881-892.
27. Boehm-Sturm P., Aswendt M., Minassian A., Michalk S., Mengler L., Adamczak J., Mezzanotte L., Lowik C., Hoehn M. A multi-modality platform to image stem cell graft survival in the naive and stroke-damaged mouse brain. Biomaterials 2014, 35:2218-2226.
28. Nguyen P.K., Riegler J., Wu J.C. Stem cell imaging: from bench to bedside. Cell Stem Cell 2014, 14:431-444.
29. Visnyei K., Tatsukawa K.J., Erickson R.I., Simonian S., Oknaian N., Carmichael S.T., Kornblum H.I. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion. Exp Neurol 2006, 197:465-474.
30. Muramatsu S., Okuno T., Suzuki Y., Nakayama T., Kakiuchi T., Takino N., Iida A., Ono F., Terao K., Inoue N., et al. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease. Synapse 2009, 63:541-548.
31. Piccini P., Lindvall O., Bjorklund A., Brundin P., Hagell P., Ceravolo R., Oertel W., Quinn N., Samuel M., Rehncrona S., et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 2000, 48:689-695.
32. Bjorklund L.M., Sanchez-Pernaute R., Chung S., Andersson T., Chen I.Y., McNaught K.S., Brownell A.L., Jenkins B.G., Wahlestedt C., Kim K.S., et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002, 99:2344-2349.
33. Hofstetter C.P., Holmstrom N.A., Lilja J.A., Schweinhardt P., Hao J., Spenger C., Wiesenfeld-Hallin Z., Kurpad S.N., Frisen J., Olson L. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2005, 8:346-353.
34. Suzuki J., Sasaki M., Harada K., Bando M., Kataoka Y., Onodera R., Mikami T., Wanibuchi M., Mikuni N., Kocsis J.D., et al. Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model. Brain Res 2013, 1497:15-22.
35. Gupta N., Henry R.G., Strober J., Kang S.M., Lim D.A., Bucci M., Caverzasi E., Gaetano L., Mandelli M.L., Ryan T., et al. Neural stem cell engraftment and myelination in the human brain. Sci Transl Med 2012, 4:155ra137.
36. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
37. Sunwoo M.K., Yun H.J., Song S.K., Ham J.H., Hong J.Y., Lee J.E., Lee H.S., Sohn Y.H., Lee J.-M., Lee P.H. Mesenchymal stem cells can modulate longitudinal changes in cortical thickness and its related cognitive decline in patients with multiple system atrophy. Front Aging Neurosci 2014, 6.
38. Lee P.H., Lee J.E., Kim H.S., Song S.K., Lee H.S., Nam H.S., Cheong J.W., Jeong Y., Park H.J., Kim D.J., et al. A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann Neurol 2012, 72:32-40.
39. 18F-FDG PET. J Nucl Med 2013, 54:668-669.
40. Wernig M., Benninger F., Schmandt T., Rade M., Tucker K.L., Bussow H., Beck H., Brustle O. Functional integration of embryonic stem cell-derived neurons in vivo. J Neurosci 2004, 24:5258-5268.
41. Espuny-Camacho I., Michelsen K.A., Gall D., Linaro D., Hasche A., Bonnefont J., Bali C., Orduz D., Bilheu A., Herpoel A., et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 2013, 77:440-456.
42. Stroh A., Tsai H.C., Wang L.P., Zhang F., Kressel J., Aravanis A., Santhanam N., Deisseroth K., Konnerth A., Schneider M.B. Tracking stem cell differentiation in the setting of automated optogenetic stimulation. Stem Cells 2011, 29:78-88.
43. Tonnesen J., Parish C.L., Sorensen A.T., Andersson A., Lundberg C., Deisseroth K., Arenas E., Lindvall O., Kokaia M. Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model. PLoS ONE 2011, 6:e17560.
44. Wang S.J., Weng C.H., Xu H.W., Zhao C.J., Yin Z.Q. Effect of optogenetic stimulus on the proliferation and cell cycle progression of neural stem cells. J Membr Biol 2014, 247:493-500.
45. Weick J.P., Johnson M.A., Skroch S.P., Williams J.C., Deisseroth K., Zhang S.C. Functional control of transplantable human ESC-derived neurons via optogenetic targeting. Stem Cells 2010, 28:2008-2016.
46. Bruegmann T., Malan D., Hesse M., Beiert T., Fuegemann C.J., Fleischmann B.K., Sasse P. Optogenetic control of heart muscle in vitro and in vivo. Nat Methods 2010, 7:897-900.
47. Bryson J.B., Machado C.B., Crossley M., Stevenson D., Bros-Facer V., Burrone J., Greensmith L., Lieberam I. Optical control of muscle function by transplantation of stem cell-derived motor neurons in mice. Science 2014, 344:94-97.
48. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 2005, 8:1263-1268.
49. Zhang F., Wang L.P., Brauner M., Liewald J.F., Kay K., Watzke N., Wood P.G., Bamberg E., Nagel G., Gottschalk A., et al. Multimodal fast optical interrogation of neural circuitry. Nature 2007, 446:633-639.
50. Lee J.H., Durand R., Gradinaru V., Zhang F., Goshen I., Kim D.S., Fenno L.E., Ramakrishnan C., Deisseroth K. Global and local fMRI signals driven by neurons defined optogenetically by type and wiring. Nature 2010, 465:788-792.
51. Desai M., Kahn I., Knoblich U., Bernstein J., Atallah H., Yang A., Kopell N., Buckner R.L., Graybiel A.M., Moore C.I., et al. Mapping brain networks in awake mice using combined optical neural control and fMRI. J Neurophysiol 2011, 105:1393-1405.
52. Fang Z., Lee J.H. High-throughput optogenetic functional magnetic resonance imaging with parallel computations. J Neurosci Methods 2013, 218:184-195.
53. Lee J.H. Informing brain connectivity with optogenetic functional magnetic resonance imaging. Neuroimage 2012, 62:2244-2249.
54. Lee J.H. Tracing activity across the whole brain neural network with optogenetic functional magnetic resonance imaging. Front Neuroinform 2011, 5:21.